Back
MoonLake Immunotherapeutics Stock Price Chart
NOW is the time to get in on this trillion-dollar megatrend
Get it here.
Sell
43
MLTX
MoonLake Immunotherapeutics
Last Price:
42.36
Seasonality Move:
66.96%
7 Day Trial
ALL ACCESS PASS
$
7
7 Powerhouse Stocks to Buy and Hold Forever
Get it now.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MLTX is experiencing slight buying pressure.
MoonLake Immunotherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 42.55 | Sell |
| 20-day SMA: | 44.9 | Sell |
| 50-day SMA: | 48.47 | Sell |
| 200-day SMA: | 52.9 | Sell |
| 8-day EMA: | 42.83 | Sell |
| 20-day EMA: | 44.61 | Sell |
| 50-day EMA: | 47.86 | Sell |
| 200-day EMA: | 47.5 | Sell |
MoonLake Immunotherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.97 | Sell |
| Relative Strength Index (14 RSI): | 36.58 | Sell |
| Chaikin Money Flow: | 117398 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.81 - 49.53) | Sell |
| Bollinger Bands (100): | (46.79 - 59.05) | Sell |
MoonLake Immunotherapeutics Technical Analysis
| Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for MoonLake Immunotherapeutics Stock
Is MoonLake Immunotherapeutics Stock a Buy?
- MoonLake Immunotherapeutics share price is 42.25 while MLTX 8-day simple moving average is 42.55, which is a Sell signal.
- The stock price of MLTX is 42.25 while MoonLake Immunotherapeutics 20-day SMA is 44.90, which makes it a Sell.
- MoonLake Immunotherapeutics 50-day simple moving average is 48.47 while MLTX share price is 42.25, making it a Sell technically.
- MLTX stock price is 42.25 and MoonLake Immunotherapeutics 200-day simple moving average is 52.90, creating a Sell signal.
MLTX Technical Analysis vs Fundamental Analysis
Sell
43
MoonLake Immunotherapeutics (MLTX)
is a Sell
Is MoonLake Immunotherapeutics a Buy or a Sell?
-
MoonLake Immunotherapeutics stock is rated a Sell
The current MoonLake Immunotherapeutics [MLTX] share price is $42.25. The Score for MLTX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
MoonLake Immunotherapeutics Stock Info
Market Cap:
2.66B
Price in USD:
42.25
Share Volume:
264.83K
MoonLake Immunotherapeutics 52-Week Range
52-Week High:
64.98
52-Week Low:
20.29
Sell
43
MoonLake Immunotherapeutics (MLTX)
is a Sell
MoonLake Immunotherapeutics Share Price Forecast
-
What is the MoonLake Immunotherapeutics stock price today?
The MoonLake Immunotherapeutics stock price is 42.25 USD today. -
Will MLTX stock go up or go down?
MoonLake Immunotherapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is MoonLake Immunotherapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, MoonLake Immunotherapeutics is overvalued.
Is MoonLake Immunotherapeutics Stock a Buy?
- MoonLake Immunotherapeutics share price is 42.25 while MLTX 8-day exponential moving average is 42.83, which is a Sell signal.
- The stock price of MLTX is 42.25 while MoonLake Immunotherapeutics 20-day EMA is 44.61, which makes it a Sell.
- MoonLake Immunotherapeutics 50-day exponential moving average is 47.86 while MLTX share price is 42.25, making it a Sell technically.
- MLTX stock price is 42.25 and MoonLake Immunotherapeutics 200-day simple moving average is 47.50, creating a Sell signal.
Fundamental Analysis of MoonLake Immunotherapeutics
Is MoonLake Immunotherapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.37 per share, a decrease this year of $0.29 per share, and a decrease next year of $0.59 per share.
Technical Analysis of MoonLake Immunotherapeutics
Should I short MoonLake Immunotherapeutics stock?
- MLTX Moving Average Covergence Divergence (MACD) indicator is -1.97, suggesting MoonLake Immunotherapeutics is a Sell
- MoonLake Immunotherapeutics Relative Strength Index (RSI) is 36.58, which suggest MoonLake Immunotherapeutics is oversold
- The Bollinger Bands (25) for MoonLake Immunotherapeutics is (42.81 - 49.53), which suggest MoonLake Immunotherapeutics is a Sell
- The Bollinger Bands (100) for MoonLake Immunotherapeutics is (46.79 - 59.05), which suggest MoonLake Immunotherapeutics is a Sell
* MoonLake Immunotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.